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Abstract: Recent studies from our laboratory
have demonstrated that ascorbate potentiated en-
zymatic synthesis of nitric oxide (NO) from poly-
morphonuclear leukocytes (PMNs). NO is known
to modulate various function of PMNs such as che-
motaxis, adherence, aggregation, and generation
of reactive oxygen species (ROS). The role of
ascorbate in the PMN phagocytosis, ROS genera-
tion, and apoptosis was thus evaluated in the
present study. Ascorbate and its oxidized and cell-
permeable analog, dehydroascorbate (DHA), did
not affect the phagocytosis but enhanced ROS gen-
eration and apoptosis following treatment with
Escherichia coli or arachidonic acid. A detailed
investigation on the DHA-mediated response indi-
cated that inhibitors of DHA uptake, reduced nic-
otinamide adenine dinucleotide phosphate oxidase,
NO synthase, or ROS scavengers attenuated ROS
generation. In DHA-treated cells, enhanced gener-
ation of peroxynitrite was also observed; thus,
ascorbate-mediated ROS and reactive nitrogen
species generation might mediate cytotoxicity to-
ward the ingested microbes and subsequently, aug-
mented PMN apoptosis. Results of the present
study have helped in delineating the role of ascor-
bate in the modulation of NO-mediated ROS gen-
eration from PMNs. J. Leukoc. Biol. 75:
1070–1078; 2004.
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INTRODUCTION
Nitric oxide (NO), an immunomodulator molecule, regulates
various functions of lymphocytes, macrophages, and polymor-
phonuclear leukocytes (PMNs). The role of NO is proposed in
chemotaxis, adhesion to endothelium, aggregation, and in the
PMN-mediated tissue damage [1]. PMNs synthesize superoxide
anion (O2
.–) by the one-electron reduction of oxygen at the
expense of reduced nicotinamide adenine dinucleotide phos-
phate (NADPH) [2]. Studies from this laboratory as well as
from others have demonstrated that NO modulates reactive
oxygen species (ROS) generation from PMNs [1, 3, 4]. In
addition to ROS scavenging, NO attenuated NADPH oxidase
activity [5] and inhibited ROS generation, and a NO-dependent
increase in the intracellular calcium augmented ROS genera-
tion [4]. NO-mediated modulation of ROS generation has also
been demonstrated in the conditions associated with the in-
creased accumulation of NO, such as hypoxia-reoxygenation
[1, 4, 6] and lipopolysaccharide treatment [7].
Conversely, interaction of NO with O2
.– leads to the forma-
tion of cytotoxic species, peroxynitrite (ONOO.–) and hydroxyl
radicals [8, 9]. PMNs store high amounts of L-ascorbic acid,
and activated PMNs recycle ascorbic acid/dehydroascorbate
(DHA) [10, 11]. The precise reason for storing such high
concentrations of ascorbic acid was not defined clearly. Studies
from our laboratory have recently shown for the first time that
ascorbate increased the availability of NO from PMNs by
stabilizing tetrahydrobiopterin [12, 13]. As ascorbate affects
the generation of NO from PMNs, it was considered worthwhile
to investigate the effect of ascorbate or its oxidized product
DHA on PMN functions such as phagocytosis, apoptosis, ROS,
and reactive nitrogen species (RNS) generation.
MATERIALS AND METHODS
Chemicals
7-Nitro indazole (7-NI) and trifluoperazine (TFP) were purchased from RBI
(Natick, MA). Annexin V binding assay kit, purified Annexin V, monoclonal
anti-rat CD11b–fluorescein isothiocyanate (FITC), anti-rat CD45–phyco-
erythrin (PE), anti-human CD15–FITC, and anti-human CD45–PE were pur-
chased from Becton Dickinson (San Jose, CA), and all other chemicals were
procured from Sigma Chemical Co. (St. Louis, MO).
Animals and humans
Sprague Dawley rats (male, 180–200 g) were obtained from the animal house
of Central Drug Research Institute (Uttar Pradesh, India). They were housed in
polypropylene cages and provided with chow pellets and water ad libitum. To
ascertain the results obtained in rats, we performed one set of experiments in
venous monkey blood obtained from the Rhesus monkeys housed in the
institute’s animal house. We also performed studies on human blood obtained
from male, healthy volunteers. All subjects were nonfasted and normotensive
with no evidence of anemia, renal, or hepatic dysfunction. None of the donors
were using antioxidants, vitamins, or nutritional supplements for at least 4
weeks before the blood collection. Animal handling and all the experiments
were conducted according to the ethical guidelines of the institute.
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Preparation of ascorbic acid and DHA acid
solutions
Stock solution (10 mM) of L-ascorbic acid and DHA were prepared fresh in
Milli Q water just before the use, pH of the solution was adjusted to 7.0 with
1 N NaOH, and dilutions of the stock solutions (ascorbate or DHA) were made
in Hank’s balanced salt solution [HBSS; composition, mM: sodium chloride
(NaCl), 138; potassium chloride, 2.7; disodium hydrogen phosphate, 8.1;
potassium dihydrogen phosphate, 1.5; diethylenetriamine penta acetic acid,
0.1; pH 7.4; ref. 12].
Isolation of PMNs
Rat blood was collected under ether anesthesia by cardiac puncture in sodium
citrate (0.129 M, pH 6.5, 9:1 v/v). Human or monkey venous blood was also
collected in sodium citrate (0.129 M, pH 6.5, 9:1 v/v). Platelet-rich plasma was
removed by the centrifugation of blood at 250 g for 20 min at 20°C (Sigma
Centrifuge, Germany). Buffy coat was collected after centrifugation of the
remaining blood at 1000 g for 20 min at 20°C. The buffy coat was subjected
to dextran sedimentation and Histopaque gradient at 700 g for 30 min at 20°C
as described earlier [12]. PMNs were harvested at the interface of Histopaque
1119/1077 and were washed three times with HBSS. Cell viability was tested
by trypan blue exclusion test. Purity of rat PMNs was checked by labeling with
anti-rat CD11b–FITC and anti-rat CD45–PE and for human PMNs, with
anti-human CD15–FITC and anti-human CD45–PE monoclonal antibodies,
according to instructions provided by the manufacturer (Becton Dickinson)
using a flow cytometer (FACSCalibur, Becton Dickinson), which was always
more than 90%.
ROS generation
PMNs (2106 cells/ml) were incubated for 5 min with 2, 7 dichlorodihy-
drofluorescein diacetate (DCDHF-DA; 10 M) and were then treated with
ascorbate or DHA for 15 min at 37°C. Arachidonic acid [AA; 2 M; formyl-
Met-Leu-Phe (fMLP), 5 M] and phorbol 12-myristate 13-acetate (PMA; 30
nM) were used to induce the free radical generation, and cells were incubated
further at 37°C for 15 min. In another set of experiments, PMNs (2106
cells/ml) were preincubated for 5 min with DCDHF-DA (10 M), and then
ascorbate or DHA and bacteria (1–2107 cells/ml) were added to further
incubate for 30 min at 37°C. Each sample was evaluated on a FACSCalibur
(Becton Dickinson). Fluorescence of 10,000 cells was acquired by gating the
PMN population and was analyzed by the Cell Quest program to determine the
mean fluorescence. To determine the effect of various interventions, cells were
incubated at 37°C with NADPH oxidase inhibitor diphenyleneiodonium (DPI)
or NO synthase (NOS) inhibitor 7-NI for 30 min, NO scavenger 2-(4-carboxy-
phenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO), ONOO.– scav-
enger mercaptoethylguanidine (MEG), or iodoacetamide for 15 min and for 5
min with ROS scavengers superoxide dismutase (SOD) and catalase, myelo-
peroxidase (MPO) inhibitor 4-aminobenzoicacid hydrazide (ABAH), calmod-
ulin (CaM) antagonist TFP, or DHA transport inhibitor (D-glucose) before
loading with the dye. The interventions used in the study and ascorbate/DHA
were analyzed for their per se effect on the DCDHF-DA fluorescence in
isolation or in combination on a fluorimeter (RF5000, Schimadzu, Japan). None
of these interventions, alone or in combination with ascorbate/DHA, exhibited
any significant effect on the fluorescence to DCDHF-DA. In one set of
experiments, dihydroethidium (DHE; 10 M) was used to assess the effect of
ascorbate or DHA (300 M) on the superoxide radical generation.
Generation of ROS from PMNs has been reported as mean stimulation index
(MSI) as described earlier [7], which is the ratio of mean fluorescence of the
stimulated and unstimulated cells. In all the experiments, MSI was calculated
using respective control from the same experiment.
Phagocytosis
A flow cytometry-based method was used to study the bacterial phagocytosis by
the rat and human PMNs as described previously [14]. Bacteria (Escherichia
coli) were heat-inactivated at 60°C for 30 min before the labeling with FITC
(50 g/ml) in the dark with continuous stirring for 60 min at room temperature.
Labeled bacteria were washed three times with HBSS, declumped, and resus-
pended in HBSS. PMNs (2106 cells) were incubated with FITC-labeled
bacteria (1–2107 cells/ml) for 30 min at 37°C in the presence or absence of
ascorbate/DHA and were then washed and analyzed immediately by the
FACSCalibur. To differentiate adherent from ingested, fluorescent bacteria,
trypan blue (2 mg/ml for 5 min) was added to the samples after the first
measurement on the FACSCalibur (Becton Dickinson), and the samples were
analyzed again.
Annexin V binding
Annexin V FITC binding was performed according to the protocol of Becton
Dickinson. Control PMNs (2106cells/ml), ascorbate/DHA, bacteria (E. coli),
and DHA-treated cells were incubated for 30 min at 37°C and were washed
with cold HBSS. Cells were resuspended in 100 l binding buffer [10 mM
HEPES/NaOH (pH 7.5), 140 mM NaCl, 2.5 mM CaCl2] and were incubated
with 5 l Annexin V FITC in the dark at room temperature [15]. After
incubation, 400 l binding buffer was added, and cells were subsequently
analyzed by the FACSCalibur (Becton Dickinson). Specific binding of FITC–
Annexin V was confirmed by incubating the PMNs with 10 g blocking
peptide (purified Annexin V) before incubation with FITC Annexin V as
mentioned in the protocol.
Estimation of ONOO.–
Nitrate estimation
The Griess reagent measured nitrate content in the PMNs (1107 cells). Cells
following treatment with ascorbate/DHA were sonicated on ice and were
centrifuged at 2000 g for 20 min at 4°C; thus, the supernatant obtained was
stored at –20°C. Supernatants were freeze-dried and than reconstituted with 1
ml 0.7 M ammonium chloride. Each sample was divided into two fractions—
one of them was treated with cadmium pellets so as to reduce the nitrate
content to nitrite. Samples were treated with an equal amount of Griess reagent
and incubated for 30 min at 37°C. Concentration of nitrite was estimated by
measuring optical density at 548 nm using sodium nitrite as standard. Nitrite
content in the samples not treated with cadmium was subtracted from total
nitrite content (treated with cadmium) to obtain the nitrate content [16].
Estimation of 4-hydroxy-3-nitrophenylacetic (HPA) acid
HPA and its nitration product, 3-nitro-4-hydroxyphenyl acetic acid (3-nitro-
HPA), were estimated in PMNs treated with ascorbate or DHA, according to
Eiserich et al. [17] with minor modifications. Briefly, PMNs (3107cells/ml in
HBSS) were treated with HPA (1 mM) before the addition of ascorbate/DHA,
and the reaction mixture was incubated at 37°C for 15 min. Subsequently, the
cells were stimulated with AA (30 M) for 15 min, and reaction was terminated
by the addition of N-acetylcysteine (1 mM). The cell suspension was sonicated
and centrifuged at 10,000 g for 20 min at 4°C, and the supernatant was passed
through 10K cut-off filters. HPA and 3-nitroHPA in the filtrate were analyzed
by high-pressure liquid chromatography (HPLC; LaChrom, Merck-Hitachi,
Germany), using a LiChrospher 100 RP-18 column (5 m, Merck-Hitachi),
and 65% (50 mM) potassium phosphate (pH 3.0) and 35% methanol as mobile
phase, using an ultraviolet detector at 274 nm. Identification and quantification
of 3-nitroHPA and HPA were performed using external standards.
Detection of 3-nitrotyrosine
AA-stimulated PMNs treated with vehicle or DHA were harvested and fixed
with 80% MeOH on ice for 20 min. Immunolabeling was performed in the fixed
cells by incubating with a 1:200 dilution of polyclonal antibody to nitrotyrosine
as primary antibody for 2 h. Cells were washed twice and stained with
FITC-conjugated goat anti-rabbit immunoglobulin G for 1 h. Cells were washed
three times before analysis by FACSCalibur (Becton Dickinson) [18]. AA-
stimulated PMNs were labeled with secondary antibody alone and considered
as controls.
Measurement of dihydrorhodamine 123 (DHR-123)
fluorescence
PMNs (2106 cells/ml) were preincubated for 5 min with DHR-123 (5 M)
and then treated with ascorbate or DHA for 15 min at 37°C before stimulation
with AA (2 M). Each sample was evaluated on a FACSCalibur (Becton
Dickinson). Fluorescence of 10,000 cells was acquired by gating the PMN
population and was analyzed by the Cell Quest program to determine the mean
fluorescence [19].
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Free radical generation from PMNs has been reported as MSI, as described
earlier [7], which is the ratio of mean fluorescence of the stimulated and
unstimulated cells. In all the experiments, MSI was calculated using respective
control from the same experiment.
Statistical analysis
Results have been expressed as mean  SE of at least five independent
experiments in each group. Comparisons between two different groups were
performed by unpaired Student’s t-test or Welsh test, and multiple compari-
sons were made by one-way ANOVA followed by Newman Keul’s test. Results
were considered significant at P  0.05.
RESULTS
Effect of ascorbate/DHA on bacterial
phagocytosis and apoptosis
Phagocytosis of FITC-labeled E. coli by rat (Fig. 1A) or human
PMNs (Fig. 1C) was not significantly altered in the presence of
ascorbate or its cell-permeable analog DHA (300 M; Fig. 1a),
although ROS generation following phagocytosis was signifi-
cantly enhanced (Fig. 1b). Annexin V binding to the PMNs
following incubation with E. coli also was significantly aug-
mented. In the presence of DHA, it was further increased.
Blocking peptide, which was completely inhibited, assessed
the specificity of Annexin V antibody binding (Fig. 1c). Similar
trends of results were also observed in human PMNs (Fig.
1C, c).
Effect of ascorbate/DHA on ROS generation
A detailed investigation was undertaken to explore the effect of
ascorbate/DHA on ROS generation in DCDHF-DA-loaded
cells. Ascorbate or DHA did not interact directly with DCF to
affect its fluorescence. Generation of ROS from PMNs was
however significantly augmented in a time- and concentration-
dependent manner by ascorbate/DHA (100 and 300 M) in rat
PMNs (Fig. 2, a and b). A similar increase in ROS generation
was also observed in stimulated PMNs from monkeys and
humans (Fig. 2, c and d, respectively).
AA (2 M)-, fMLP (5 M)-, or PMA (30 nM)-induced free
radical generation was significantly enhanced in the presence
of DHA (300 M; Fig. 3). Pretreatment of PMNs with glucose
(10 mM) or iodoacetamide (1 mM) to inhibit the DHA uptake
Fig. 1. Effect of ascorbate (As)/DHA on (a) phagocytosis, (b) ROS generation, and (c) apoptosis in the (A) rat and (C) human PMNs. A representative
fluorescein-activated cell sorter (FACS) histogram showing phagocytosis, free radical generation, and apoptosis is given (B). (a) PMNs (2106 cells) were incubated
with FITC-labeled bacteria for 30 min at 37°C in the presence or absence of ascorbate/DHA and were then washed and analyzed immediately by FACS for
assessment of phagocytosis. (b) For estimation of ROS generation, PMNs (2106 cells/ml) were preincubated for 5 min with DCDHF-DA (10 M) and then treated
simultaneously with ascorbate/DHA and bacteria (1–2107cells/ml) for 30 min at 37°C and analyzed by flow cytometry. (c) Apoptosis was detected in PMNs
(2106 cells/ml) treated with bacteria and DHA for 30 min at 37°C and then washed with cold HBSS. Cells were resuspended in binding buffer, labeled with
Annexin V FITC, and analyzed by flow cytometry. Data are expressed as mean  SEM of at least three independent experiments in each group. *, P  0.05, with
respect to control in the presence of bacteria.
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or conversion of DHA to ascorbate, respectively, significantly
reduced the increase in ROS generation from PMNs (Fig. 4).
Generation of ROS was also confirmed by using ROS scav-
engers, i.e., SOD (100 U/ml) and catalase (500 U/ml), which
inhibited the increase in MSI (Fig. 5). Furthermore, ROS
generation from DHA-treated cells or AA-stimulated PMNs
pretreated with DHA (300 M) was inhibited significantly on
pretreatment with NADPH oxidase inhibitor DPI (10 M) and
CaM antagonist TFP (100 M). Inhibitor of MPO, ABAH (100
M), however, had no significant effect on the DHA response
(Fig. 5). DHA and ascorbate at 300 M concentration aug-
mented the DHE fluorescence indication generation of super-
oxide radicals (Fig. 6).
Fig. 2. Time- and concentration-dependent
changes in ROS generation, as measured by
flow cytometry using DCDHF-DA in PMNs
treated with ascorbate/DHA. (a) Time-depen-
dent increases in free radical generation fol-
lowing treatment of rat PMNs with 100 M
ascorbate or 100 M DHA and 100 M
DHA  AA (2 M). Data are expressed as
mean  SEM of at least five independent exper-
iments. *, P  0.05, ** P  0.01, in compar-
ison to free radical generation after 10 min of
incubation. (b) Effect of ascorbate (100 and
300 M) and DHA on AA induced free radical
generation in rat PMNs. Data are expressed as
mean  SEM of at least 15 independent exper-
iments. (c and d) Effect of 300 M ascorbate
on AA stimulated free radical generation in
monkey and human PMNs, respectively. Data
are expressed as mean  SEM of at least three
independent experiments in monkeys and three
experiments in humans. *, P  0.05, **, P 
0.01, and ***, P  0.001, from stimulated
cells.
Fig. 3. Effect of DHA (300 M) alone and on AA (2 M)-, fMLP (5 M)-, and
PMA (30 nM)-induced free radical generation. *, P  0.05, **,P  0.01, with
respect to the control; #, P  0.05, in comparison with DHA (300 M)-treated
PMNs.
Fig. 4. Effect of inhibition of DHA transport or its conversion to ascorbate
(Asc) on ROS generation measured by flow cytometry in DHA- and AA-
stimulated rat PMNs (2106 cells/ml), which were incubated with inhibitor of
glucose transporter (GLUT)1, D-glucose (10 mM) for 5 min, or inhibitor of
glutaredoxin, iodoacetamide (1 mM), for 15 min at 37°C before DCDHF-DA
(10 M) loading, addition of ascorbate, or DHA (300 M), alone or with AA
(2 M). Data are represented as mean  SEM of at least six independent
experiments in each group. #, P  0.05, in ascorbate or DHA-treated and
AA-stimulated PMNs in comparison with ascorbate or DHA-treated PMNs;
@, P 0.01, in the glucose or iodoacetamide pretreated PMNs after ascorbate/
DHA addition alone or with AA in comparison with the respective control.
*, P  0.05; **, P  0.01, in comparison with the AA-treated control of the
vehicle group.
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Modulation of DHA-mediated ROS generation by
NO interventions
Previous studies from our group have implicated the modula-
tion of ROS generation from PMNs by NO [4, 6]. To investigate
this phenomenon, PMNs were pretreated with a NOS inhibitor,
7-NI (1 mM), a NO scavenger, cPTIO (30 M), or a scavenger
of NO and ONOO.–, MEG (100 M). None of these interven-
tions attenuated the DCDHF-DA fluorescence in the resting
PMNs. Inhibition of NOS with 7-NI attenuated the ROS gen-
eration in the DHA-treated cells or A-stimulated PMNs, and
cPTIO and MEG inhibited the AA-induced stimulation com-
pletely, suggesting the involvement of NO in the PMN ROS
generation (Fig. 6) [4]. Moreover, the scavengers of NO,
ONOO.– , and inhibitors of NOS significantly attenuated the
increase in ROS generation, also from DHA-treated PMNs
(Fig. 7).
Generation of ONOO.– from PMNs treated with
ascorbate/DHA
Nitrite accumulation correlates well with the formation of NO
in cellular suspensions, and nitrate formation is considered to
be a result of haemoglobin contamination with the generation of
ONOO.–. PMNs treated with DHA (100 or 300 M) showed a
significant increase in the nitrate levels (Fig. 8A). Stimulation
of PMNs with AA attenuated the nitrate content in control as
well as DHA (300 M)-treated PMNs. The nitrate content
however, in AA-stimulated PMNs pretreated with DHA still
remained significantly higher in comparison with the control
(Fig. 8A).
ONOO.– formation was assessed by 3-nitroHPA formation in
activated PMNs in the presence of ascorbate or DHA. Forma-
tion of 3-nitroHPA was augmented in PMNs treated with
ascorbate and AA, which was further enhanced in 300 M
DHA-pretreated, AA-stimulated cells (Fig. 8B).
ONOO.– synthesis was also confirmed by nitrotyrosine anti-
body binding to the DHA-treated PMNs stimulated with AA by
flow cytometry. Stimulated PMNs treated with DHA (300 M)
showed increased binding of antinitrotyrosine compared with
stimulated PMNs alone (Fig. 8C).
Increase in the fluorescence of PMNs labeled with DHR-123
on treatment with 300 M ascorbate or DHA also indicated
augmented formation of ONOO.– (Fig. 8D). Similar to nitroty-
rosine antibody binding, fluorescence to AA  DHA-treated
PMNs was higher compared with AA-treated cells.
Fig. 5. Mechanism of augmented ROS generation on ascorbate/DHA treat-
ment and in AA-stimulated PMNs. Effect of NADPH oxidase inhibitor, DPI (10
M), CaM antagonist, TFP (100 M), or scavengers of ROS, SOD (100 U/ml),
and catalase (500 U/ml), MPO inhibitor, ABAH (100 M), on DHA or DHA
AA-induced ROS generation using DCDHF-DA. Data are represented as
mean  SEM of at least four independent experiments. *, P  0.05; **, P 
0.01, in AA-stimulated, receiving various treatments, in comparison with
AA-stimulated PMNs receiving no treatment (HBSS). @, P  0.01, in the
presence of various interventions in comparison with DHA-treated control
PMNs. #, P  0.01, in the presence of various inhibitors/scavengers in
comparison with DHA (300 M) AA-treated, control PMNs.
Fig. 6. Effect of ascorbate (Asc) or DHA (300 M) on superoxide radical
generation. For estimation of superoxide radical generation, PMNs (2106
cells/ml) were preincubated for 5 min with DHE (10 M) and then treated with
ascorbate or DHA (300 M).
Fig. 7. Modulation of ROS generation on DHA-treated PMNs on AA stimu-
lation by NO. Effect of NOS inhibitor 7-NI (1 mM, 30 min); NO scavenger
cPTIO (30 M, 15 min), and ONOO.– scavenger MEG (100 M, 15 min) on
DHA- and AA (2 M)-induced free radical generation using DCDHF-DA.
Data are represented as mean SEM of at least three independent experiments
in each group. *, P  0.01; **, P  0.001, in comparison with control,
AA-stimulated cells. #, P  0.05; ##, P  0.01, in DHA-treated or DHA 
AA-stimulated PMNs pretreated with inhibitor/scavenger compared with the
respective controls.
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DISCUSSION
Results of the present study suggest that ascorbate-induced NO
availability in the PMNs leads to the enhanced free radical
generation and apoptosis, and phagocytic activity remained
unaffected.
Neutrophils store ascorbic acid at 10 mM concentration
[10, 11, 20, 21]. Bacterial phagocytosis or chemical activation
of PMNs has been shown to induce ascorbic acid recycling
[11]. The precise role of ascorbic acid in such a high concen-
tration in the neutrophil function remains less understood. In
addition to its well-established role as an antioxidant and
preserving NO [22], our recent studies have demonstrated that
ascorbate also augments NOS activity [12, 13] by stabilizing
tetrahydrobiopterin [12, 23–25]. NO is known to modulate
various functions of PMNs including ROS generation [1].
In the present study, we evaluated the effect of ascorbate/
DHA on bacterial phagocytosis, ROS, and RNS generation
subsequent to phagocytosis and also on apoptosis to elucidate
the functional importance of ascorbate-mediated augmentation
of NO generation from PMNs. Bactericidal activity of the PMNs
is associated with the activation of enzyme NADPH oxidase to
generate ROS. The role of NO and ONOO.– in bactericidal
activity is also demonstrated [8, 9]. Bacterial phagocytosis by
rat and human PMNs was not significantly altered in the
presence of ascorbate/DHA (Fig. 1a). We, however, observed
that free radical generation and binding of Annexin V antibody
(Fig. 1, b and c), following bacterial phagocytosis, were aug-
mented significantly in rat as well as human PMNs. It is
therefore apparent that bacterial elimination in ascorbate/
DHA-treated cells seems to be more efficient as a result of
enhanced free radical generation; cells also readily undergo
apoptosis to prevent inflammatory response. An ascorbate-
induced increase in lipid peroxidation and proapoptotic death
has been reported in different cell types [26–29]. It seems that
the ascorbate pool in the PMNs is used by the PMNs to destroy
Fig. 8. Effect of ascorbate/DHA treatment to the AA-stimulated PMNs on ONOO.– synthesis. (A) Nitrate content in rat PMNs (1107cells/ml) as measured with
Griess reagent. Data are represented as mean SEM of at least six independent experiments in each group. #, P 0.05; ##, P 0.01, from resting PMNs receiving
no treatment (HBSS); $, P  0.05, from stimulated control without DHA (n6–8). (B) Formation of 3-nitroHPA on pretreatment of stimulated rat PMNs (3107
cells) with HPA (1 mM) before reaction with 300 M ascorbate/DHA as observed by HPLC. Concentrations of 3-nitroHPA were interpolated from an external
standard method under the same conditions. Data are represented as mean  SEM of at least 10 independent experiments in each group. *, P  0.05, in
DHA-treated cells compared with AA-stimulated controls. (C) Labeling of PMNs with antinitrotyrosine (a, FITC-labeled secondary antibody only; b, AA-treated
cells labeled with primary and secondary antibody; and c, AADHA-treated cells labeled with primary and secondary antibody). (D) Oxidation of DHR-123
observed in FACSCalibur (a, control; b, 300 M ascorbateAA; c, 300 M DHAAA).
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the engulfed pathogens, as suggested by our results and also by
earlier observations that dietary supplementation with vitamin
C augments innate immunity [30–33].
Studies on the effect of ascorbate on ROS generation from
phagocytes are very limited, and the outcome has also re-
mained controversial. These studies have shown increase [34–
36], decrease [37], and even no change [30]. Previous studies
from our laboratory have demonstrated modulation of ROS
generation from the stimulated PMNs by NO [4, 6, 38, 39].
Ascorbate and its oxidized product, DHA, modulated the gen-
eration of NO from the PMNs [12, 13]. In the present study, we
evaluated the modulatory role of ascorbate-mediated NO on the
ROS generation from E. coli and AA-, fMLP-, and PMA-
stimulated PMNs. As free radical generation was measured by
flow cytometry, to elucidate the mechanism involved in ascor-
bate/DHA-mediated, enhanced free radical generation, we
used a soluble and direct activator of NADPH oxidase, AA
[40]. DCDHF-DA, the dye used in the present study to assess
free radical generation, has been shown to react readily with
H2O2 but also exhibits some reactivity with ONOO
.– [40, 41].
Ascorbate is oxidized readily to DHA in the aerated buffer
and is subsequently transported into the PMNs by the GLUT1
transporter, which is further enhanced in activated PMNs [42].
Ascorbate/DHA elicited a time-dependent increase in the ROS
generation even from resting cells (Fig. 2a), which was further
enhanced on stimulation of rat PMNs with AA (Fig. 2b). The
increase in ROS generation on ascorbate addition was also
seen in PMNs obtained from monkey and human (Fig. 2, c and
d, respectively). Inhibition of DHA uptake of by D-glucose [42]
or conversion of DHA to ascorbate by iodoacetamide [12]
reduced ROS generation (Fig. 4). Iodoacetamide is shown to
inhibit a DHA-mediated increase in NO generation [12]. The
enhanced ROS generation from AA-stimulated PMNs on DHA
(300 M) treatment was sensitive to DPI, a NADPH oxidase
inhibitor, as well as to scavengers of ROS, i.e., SOD and
catalase (Fig. 5), and ABAH, a MPO inhibitor, had no effect.
DPI interferes with the flavin adenine dinucleotide binding to
the enzyme NADPH oxidase and can also inhibit NOS [43].
Results obtained thus suggest that the increase in ROS gen-
eration was mediated by NO and was a result of the enzymatic
synthesis of ROS.
Involvement of NO was also indicated by the inhibition of
ROS generation from AA-stimulated PMNs on DHA (300 M)
treatment by a NOS inhibitor, 7-NI, or NO scavenger, cPTIO
(Fig. 7). In the AA-stimulated PMNs, inhibition of ROS gen-
eration in the presence of NO scavenger implicates the involve-
ment of NO in ROS generation. A biphasic role of NO has been
demonstrated on the free radical generation from the PMNs [3,
4, 6, 38, 44]. Low or physiological concentrations (10–100
nM) of NO potentiated ROS generation, but higher concentra-
tions attenuated ROS generation from the rat PMNs [4]. The
results from our earlier studies have indicated that treatment of
PMNs with ascorbate led to the increase in NO generation [12,
13]. NO-mediated modulation of ROS generation from the
PMNs indicates the possible role of ascorbate, which was not
demonstrated earlier. To our knowledge, the present study is
the first report of ascorbate-mediated augmentation of NO-
dependent ROS generation.
Formation of NO and ROS on treatment of PMNs with
ascorbate or DHA necessitated the estimation of ONOO.–; its
formation in PMNs was confirmed by using various methods
such as nitrate content, HPA acid estimation by HPLC, nitro-
tyrosine antibody binding, or DHR-123 fluorescence measure-
ment by flow cytometry (Fig. 8). ONOO.–, a powerful oxidant,
reacts with protein and nonprotein thiol residues [45], inhibits
some enzymes of the mitochondrial electron transport chain
[46], promotes lipid peroxidation [47], and finally, leads to
mitochondrial permeability transition and apoptosis [46, 48].
Although ascorbic acid has been shown to attenuate the dele-
terious effect of this oxidant [49], our study exhibited that in
PMN ascorbate, enhanced AA and E. coli induced ROS gen-
eration, as also observed by Guidarelli et al. [50] in U937 cells.
It seems that supplementation of ascorbate in vitro to the PMNs
increased the oxidative and nitrosative stress, which might be
used by PMNs for effective bactericidal activity. Ascorbic
acid has also been reported to act as a pro-oxidant under
inflammatory conditions and increases nitrosative stress [2,
6, 50 –52].
Circulating concentrations of ascorbate in normal, healthy
individuals is in the micromolar range (50–200 M), DHA
concentration is several-fold less than ascorbate [20], and
these concentrations exert a negligible effect on ROS genera-
tion. Ascorbate consumption and DHA accumulation observed
during prolonged oxidative stress or pathophysiological states
are characterized by a dominancy of pro-oxidant effects (e.g.,
diabetes mellitus) [53, 54]. DHA accumulation might be re-
sponsible, at least partly, for the oxidative stress associated
with these pathologies. On the basis of the present study, it is
however difficult to interpret that ascorbate per se might have
proinflammatory effects, as ascorbate oxidation in plasma will
be minimal, and ascorbate/DHA also promotes apoptosis. To
investigate further the importance of ascorbate-mediated reg-
ulation of ROS generation, studies on scorbutic guinea pigs
will be useful and are being pursued in our laboratory.
The present study demonstrated that ascorbate plays a sig-
nificant role in the regulation of PMN functions. Activation of
NADPH oxidase following E. coli or AA treatment in the
presence of ascorbate/DHA augmented the ROS generation,
which was sensitive to NOS inhibition. Increased ROS and NO
availability also enhanced ONOO.– formation, which in part,
might contribute to the cytotoxicity subsequent to phagocytosis
and initiates the apoptotic cascade in these cells. Results of the
present study have helped systematically to delineate the phys-
iological importance of ascorbate in microbicidal activity of
PMNs by the enhanced free radical generation and apoptosis.
Thus, NO seems to play a significant role in the ascorbate-
mediated modulation of PMN function.
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